This episode will make a great companion for a long drive.
A blueprint for choosing the right fish oil supplement — filled with specific recommendations, guidelines for interpreting testing data, and dosage protocols.
Whereas the common form of Alzheimer's disease is characterized by memory loss and the inability to form new memories, one subtype of the disease is characterized by profound deficits in organizational skills, math capabilities, and visual perception. It is associated with toxic burden, and it typically manifests early in life. A key player in the pathogenesis of this subtype is zinc deficiency. Zinc is an essential nutrient that participates in metabolism, cognitive function, and immune response. In this clip, Dr. Dale Bredesen describes the role that zinc status plays in the development of the toxic form of Alzheimer's disease.
Rhonda: I think I also read one in your papers where you did this metabolic profiling there was a very prominent zinc deficiency in that.
Dale: Yes, so for reasons that we don't entirely understand yet, many of the people with the type 3, the toxic sub-type have low serum zinc, high copper-zinc ratios, and low triglycerides. The low triglycerides may turn out to be related to malabsorption, we don't know for sure yet, but we don't really understand why the people often have these low copper-zinc ratios.
Rhonda: What does that mean, the copper-zinc ratio, what is that?
Dale: The high copper-zinc ratio, low zinc.
Rhonda: Low zinc, yeah.
Dale: Yeah, so as, you know, copper and zinc actually are competitive, for example, in their absorption. And so, too much of one actually is often associated with too little of another. And then typically in our society, as you know, most of us are deficient in zinc. There are actually about a billion people on Earth is the estimate for zinc deficiency. It's a very common problem because if you have poor gastric acidity, which is common as we age, if you're taking PPIs for GERD, if you're taking something for reflux, you won't absorb the zinc very well, if you have copper piping which most of us do, the copper will often compete with the zinc. And so many people have a little too much copper and a little bit too little zinc. And in fact, it was noted over 30 years ago that people with high copper-zinc ratios tended to have dementia more than those with normal copper-zinc ratios.
Rhonda: Wow. So does this have something to do with it? I know there's like over 300 to 500 different enzymes in the body that require zinc. So does copper then bind to those enzymes and then sort of mess up the function or is that like the theory?
Dale: So, no. The theory is that, as you know, copper is a generator of free radicals. You know, copper can act like iron in that sense. It has a free electron in the D orbital which does not occur with zinc. So in general, as you indicated, in these various enzymes, and it's hundreds, just as you said, it is an important structural component and it has a very specific architecture with the enzymes that it serves, so it is a structural thing in general. And copper, to my knowledge, doesn't actually replace that. But for example, zinc is important in many things that are related to cognitive decline, it's important in diabetes, it's important in functioning of insulin, it's important, of course, in the trophic activity of insulin and, you know, on and on. It's important in immune responses. So, it actually has many effects that are related to cognition.
Rhonda: So it may even just be a biomarker for something underlying going on right in the toxic insult type of Alzheimer's disease you're talking about.
Dale: It something to keep in mind when you see that, and especially if the person presents, and these people tend to be very distinctive, the people who have type 3. So, they tend to be young, and we see them in their late 40s, mid 50s very commonly. We've seen them as late as starting their first symptoms in the mid-60s, but typically, their first symptoms are currying in the 40s and 50s. They are often women, they are often ApoE4 negative although not always. There are certainly people who are ApoE4 positive to have this. As you mentioned, they often have the low zinc, and then they typically present in a non-amnestic way. Interestingly, unless they are homozygous for E4, in which case they do present typically with an amnestic presentation, but the ones who are E4 negative typically present with problems, as I mentioned earlier, executive dysfunction problems.
And so I always ask people, are you having trouble organizing things? We had one person, for example, who was known for her tremendous organizing capability and as she started to get the problem she just lost it. She could not organize things that she could do before, it's a very common complaint. Or as I said, people will say, "Oh, I can't calculate a tip anymore, or I can't pay the bills anymore," anything that is math-related or visual perception or word finding, things like that.
A neurodegenerative disorder characterized by progressive memory loss, spatial disorientation, cognitive dysfunction, and behavioral changes. The pathological hallmarks of Alzheimer's disease include amyloid-beta plaques, tau tangles, and reduced brain glucose uptake. Most cases of Alzheimer's disease do not run in families and are described as "sporadic." The primary risk factor for sporadic Alzheimer's disease is aging, with prevalence roughly doubling every five years after age 65. Roughly one-third of people aged 85 and older have Alzheimer's. The major genetic risk factor for Alzheimer's is a variant in the apolipoprotein E (APOE) gene called APOE4.
Characterized by amnesia. Amnestic disorders involve loss of memories (retrograde) and/or the inability to form new memories or learn new information (anterograde).
One of three common genetic variants of the APOE (apolipoprotein E) gene. The APOE4 allele, which is present in approximately 10-15% of people, increases the risk of developing Alzheimer's disease and lowers the age of onset. Having one copy of E4 increases risk 2- to 3-fold, while having two copies increases risk as much as 15-fold.
A measurable substance in an organism that is indicative of some phenomenon such as disease, infection, or environmental exposure.
A general term referring to cognitive decline that interferes with normal daily living. Dementia commonly occurs in older age and is characterized by progressive loss of memory, executive function, and reasoning. Approximately 70 percent of all dementia cases are due to Alzheimer’s disease.
A term used in chemistry to describe one of the four orbitals surrounding an atom. The D orbital contains five electrons, each having defined energy levels.
Any of a group of complex proteins or conjugated proteins that are produced by living cells and act as catalyst in specific biochemical reactions.
A range of cognitive, emotional, and behavioral difficulties that commonly occur after injury to or deterioration of the frontal lobes of the brain. A person who experiences loss of executive functions may have problems with planning, organization, flexible thinking, social behavior, decision making, emotional control, and concentration.
A digestive disorder, also known as acid reflux. GERD is characterized by burning pain in the upper abdomen, chest, and back. Treatment of GERD usually focuses on dietary and lifestyle modifications and pharmaceutical measures to reduce stomach acid production, and includes proton pump inhibitors, histamine blockers, and over-the-counter antacids.
A peptide hormone secreted by the beta cells of the pancreatic islets cells. Insulin maintains normal blood glucose levels by facilitating the uptake of glucose into cells; regulating carbohydrate, lipid, and protein metabolism; and promoting cell division and growth. Insulin resistance, a characteristic of type 2 diabetes, is a condition in which normal insulin levels do not produce a biological response, which can lead to high blood glucose levels.
A class of drugs that reduce acid production in the stomach. PPIs are used to treat dyspepsia (indigestion), peptic ulcer disease, gastrointestinal reflux disease (also known as GERD), and other gastrointestinal diseases. Proton-pump inhibitors may alter absorption of dietary minerals, a potential mechanism for an association between consumption of PPI and poorer bone health.
A digestive disorder in which acid in the stomach flows into the esophagus. Reflux can damage the esophagus over time, leading to structural and functional changes. Barrett’s esophagus is a type of precancerous condition related to reflux.
A molecule composed of a glycerol molecule bound to three fatty acids. Triglycerides are the primary component of very-low-density lipoproteins (VLDL). They serve as a source of energy. Triglycerides are metabolized in the intestine, absorbed by intestinal cells, and combined with cholesterol and proteins to form chylomicrons, which are transported in lymph to the bloodstream.
Learn more about the advantages of a premium membership by clicking below.
Every other week premium members receive a special edition newsletter that summarizes all of the latest healthspan research.